Data Disclaimer: The Nasdaq Indices and the Major Indices are delayed at least 1 minute. Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education.

There was a time cable TV seemed ubiquitous. It felt like every home had replaced the rabbit-ear antennas on top of their TV set with a cable box that brought the local channels along with popular ...

Why it matters: The verified 12-disk stacking technology represents an important move by Toshiba to stay competitive in the cloud and enterprise storage markets. In hyperscale data centers, where cost ...

This article is part of Gizmodo Deals, produced separately from the editorial team. We may earn a commission when you buy through links on the site. Reading time 2 minutes Need a new TV? Now’s the ...

We may earn a commission from links on this page. Deal pricing and availability subject to change after time of publication. Credit: Illustration by Ian Moore and product image courtesy of Amazon. The ...

The Bambu P1S is the best Bambu 3D printer for most people; this is Bambu's mid-range model and offers several useful premium features at a reasonable cost. It's almost entirely fully assembled out of ...

A regimen based on Jazz Pharma and PharmaMar's Zepzelca and Roche's Tecentriq has been approved in the US as a maintenance therapy for extensive-stage small-cell lung cancer (ES-SCLC). The approval ...

Share on Pinterest A new drug combo therapy significantly improved overall survival rates in males with locally advanced prostate cancer. Maskot/Getty Images A drug combination already used in ...

AstraZeneca has become the first company to get approval for the combination of an immunotherapy with a PARP inhibitor for treating endometrial cancer. The European Commission has cleared AZ's PD-L1 ...

The Combo Calzone is now offered at Costco locations in Phoenix, Tucson and Prescott. Costco has never issued a statement why the Combo Pizza - a cheese pizza loaded with mushrooms, olives, onion, ...

A new drug combo of enzalutamide and hormone therapy has been shown to extend survival for men with recurring prostate cancer, reducing death risk by over 40%. The study followed more than 1,000 ...

Adding the drug enzalutamide to standard hormone therapy reduced the risk of premature death by more than 40% in patients whose prostate cancer had returned, a large international clinical trial has ...